DK1299108T3 - Parasiticidt præparat samt fremgangsmåde til fremstilling af dette præparat - Google Patents

Parasiticidt præparat samt fremgangsmåde til fremstilling af dette præparat

Info

Publication number
DK1299108T3
DK1299108T3 DK01909165.1T DK01909165T DK1299108T3 DK 1299108 T3 DK1299108 T3 DK 1299108T3 DK 01909165 T DK01909165 T DK 01909165T DK 1299108 T3 DK1299108 T3 DK 1299108T3
Authority
DK
Denmark
Prior art keywords
formulation
parasiticidal
composition
solvent
animal
Prior art date
Application number
DK01909165.1T
Other languages
English (en)
Inventor
Richard Mihalik
Original Assignee
Teva Animal Health Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Animal Health Inc filed Critical Teva Animal Health Inc
Application granted granted Critical
Publication of DK1299108T3 publication Critical patent/DK1299108T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017Non-human animal skin, e.g. pour-on, spot-on
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/275Nitriles; Isonitriles
    • A61K31/277Nitriles; Isonitriles having a ring, e.g. verapamil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Zoology (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK01909165.1T 2000-02-16 2001-02-12 Parasiticidt præparat samt fremgangsmåde til fremstilling af dette præparat DK1299108T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/504,830 US6340672B1 (en) 2000-02-16 2000-02-16 Parasiticidal formulation and a method of making this formulation
PCT/US2001/004538 WO2001060380A1 (en) 2000-02-16 2001-02-12 A parasiticidal formulation and a method of making this formulation

Publications (1)

Publication Number Publication Date
DK1299108T3 true DK1299108T3 (da) 2011-04-11

Family

ID=24007921

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01909165.1T DK1299108T3 (da) 2000-02-16 2001-02-12 Parasiticidt præparat samt fremgangsmåde til fremstilling af dette præparat

Country Status (8)

Country Link
US (2) US6340672B1 (da)
EP (1) EP1299108B1 (da)
AT (1) ATE495748T1 (da)
AU (3) AU3694901A (da)
DE (1) DE60143889D1 (da)
DK (1) DK1299108T3 (da)
ES (1) ES2357697T3 (da)
WO (1) WO2001060380A1 (da)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ335166A (en) * 1999-04-14 2001-11-30 Ashmont Holdings Ltd Anthelmintic composition containing triclabendazole in at least one solvent
EP1197215B1 (en) * 2000-10-10 2006-03-22 Wyeth Anthelmintic compositions
US6893652B2 (en) 2001-08-27 2005-05-17 Wyeth Endoparasiticidal gel composition
GB2386066A (en) 2002-02-28 2003-09-10 Norbrook Lab Ltd Long-acting parasiticidal composition with improved bioavailability comprising a salicylanilide, a further anti-parasitic compound & a polymeric species
KR100600402B1 (ko) * 2002-05-22 2006-07-14 주식회사 엘지생명과학 피부 도포용 이버멕틴 조성물 및 그 제조방법
US7001889B2 (en) * 2002-06-21 2006-02-21 Merial Limited Anthelmintic oral homogeneous veterinary pastes
US20060205681A1 (en) * 2002-06-21 2006-09-14 Maryam Moaddeb Homogenous paste formulations
AU2006100530B4 (en) * 2002-07-19 2006-08-03 Merial Ltd Levamisole, Avermectins or similsr in pyrrolidone solvent
NZ520295A (en) * 2002-07-19 2005-04-29 Ashmont Holdings Ltd Anthelmintic formulations comprising levamisole and either an avermectin or milbemycin
US20040151759A1 (en) * 2002-08-16 2004-08-05 Douglas Cleverly Non-animal product containing veterinary formulations
AU2002952597A0 (en) * 2002-11-11 2002-11-28 Schering-Plough Pty. Limited Topical parasiticide formulations and methods of treatment
AU2003284802A1 (en) * 2002-11-27 2004-06-18 Eco Animal Health Ltd An injection of animal remedy including closantel or closantel sodium
AU2003900505A0 (en) * 2003-02-05 2003-02-20 Jurox Pty Ltd Anthelmintic composition
AU2012200544C1 (en) * 2003-02-05 2017-06-29 Jurox Pty Ltd Anthelmintic composition
UA82359C2 (uk) * 2003-04-03 2008-04-10 Schering Plough Ltd Композиція (варіанти) і спосіб лікування мікробних і паразитних інфекцій у великої рогатої худоби і інших тварин
CA2521268C (en) * 2003-04-04 2012-10-16 Merial Ltd. Topical anthelmintic veterinary formulations
GB0316377D0 (en) * 2003-07-12 2003-08-13 Norbrook Lab Ltd Parasiticidal composition
US7396819B2 (en) * 2003-08-08 2008-07-08 Virbac Corporation Anthelmintic formulations
DE10358525A1 (de) * 2003-12-13 2005-07-07 Bayer Healthcare Ag Endoparasitizide Mittel zur topischen Applikation
US7666444B2 (en) * 2004-02-02 2010-02-23 Wyeth Antiparasitic composition
NZ585223A (en) * 2004-02-03 2011-01-28 Wyeth Llc Anthelmintic composition comprising milbemycin, triclabendazole and a non-surfactant rheology modifier
RU2278661C2 (ru) * 2004-02-16 2006-06-27 Владимир Александрович Мосин Противопаразитарное средство
WO2005094210A2 (en) * 2004-03-12 2005-10-13 The Hartz Mountain Corporation Multi-action anthelmintic formulations
EP1734954A4 (en) * 2004-04-07 2007-05-30 Intervet Int Bv EFFECTIVE COMPOSITION OF A BENZIMIDAZOLE, AVERMECTIN AND PRAZIQUANTEL AND RELEVANT APPLICATION METHOD
US20060014641A1 (en) * 2004-07-13 2006-01-19 Zaghmout Ousama M Pathogen control with an oxalate (oxalic acid)
WO2006036624A2 (en) * 2004-09-24 2006-04-06 The Hartz Mountain Corporation Lipid stabilized formulations
DE102005011779A1 (de) * 2005-03-11 2006-09-14 Bayer Healthcare Ag Endoparasitizide Mittel
JP2009508853A (ja) * 2005-09-15 2009-03-05 メリアル リミテッド 駆虫製剤
GB0525093D0 (en) * 2005-12-09 2006-01-18 Norbrook Lab Ltd Veterinary composition
US20080027011A1 (en) * 2005-12-20 2008-01-31 Hassan Nached Homogeneous paste and gel formulations
EP1849363A1 (en) * 2006-03-09 2007-10-31 Cheminova A/S Synergistic combination of glutamate- and GABA-gated chloride agonist pesticide and at least one of Vitamin E or Niacin
US20070292529A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating osteoporotic conditions
US20070292535A1 (en) * 2006-06-19 2007-12-20 Tabbiner Philip S Strontium compositions and methods of treating arthritic and or osteoporitic conditions
AU2013201461B2 (en) * 2007-11-26 2015-10-29 Boehringer Ingelheim Animal Health USA Inc. Solvent systems for pour-on formulations for combating parasites
WO2009070687A1 (en) * 2007-11-26 2009-06-04 Merial Limited Solvent systems for pour-on formulations for combating parasites
PT2331068T (pt) * 2008-10-08 2017-03-13 Zoetis Services Llc Composições anti-helmínticas de benzimidazol
GB0905365D0 (en) * 2009-03-27 2009-05-13 Norbrook Lab Ltd A topical parasiticide composition
MX2011011559A (es) * 2009-05-01 2011-11-18 Wyeth Llc Parasiticidas sanguineos.
NZ594610A (en) 2011-08-16 2013-03-28 Virbac New Zealand Ltd Injectable Anthelmintic Formulations cotaining levamisole and one or more macrocyclic lactones for controlling internal parasites in ruminants
CA2867079A1 (en) 2012-03-13 2013-09-19 Bayer New Zealand Limited Long acting compositions
BR112014024833B1 (pt) * 2012-04-04 2022-10-04 Intervet International B.V. Produto farmacêutico veterinário mastigável macio, processo para sua fabricação e seu uso, bem como uso de pamoato de sódio
FR2991173B1 (fr) * 2012-06-04 2015-11-06 Virbac Composition veterinaire a administration cutanee a base d'oxyclozanide
US10656722B2 (en) * 2015-11-09 2020-05-19 Carnegie Mellon University Sensor system for collecting gestural data in two-dimensional animation
CN108653309A (zh) * 2018-05-09 2018-10-16 福建省农业科学院 一种发酵床大栏养猪驱虫方法
KR20230061465A (ko) 2020-09-04 2023-05-08 엘랑코 유에스 인코포레이티드 기호성 제형

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1194791A (en) * 1981-05-08 1985-10-08 John M. Ballany Parasiticidal pour-on compositions
AU1611383A (en) * 1982-07-02 1984-01-05 Robert Young & Company Limited Pesticidal formulation with cypermethrin
RU2097043C1 (ru) * 1994-09-16 1997-11-27 Акционерное общество "Ветеринарные препараты" Акарицидный препарат биорекс
US6193989B1 (en) * 1997-03-21 2001-02-27 Biogenesis S.A. Long acting injectable parasiticidal composition and the process for its preparation
ZA981925B (en) * 1997-03-21 1998-10-23 Biogenesis S A A long acting injectable parasiticidal composition and the process for its preparation
CN1263435C (zh) * 1998-03-19 2006-07-12 麦克公司 控制释放生物活性物质的液态聚合物组合物

Also Published As

Publication number Publication date
WO2001060380A1 (en) 2001-08-23
EP1299108A4 (en) 2007-05-30
DE60143889D1 (de) 2011-03-03
US6492340B2 (en) 2002-12-10
AU2001236949B2 (en) 2006-08-17
ATE495748T1 (de) 2011-02-15
US20020010142A1 (en) 2002-01-24
AU3694901A (en) 2001-08-27
EP1299108B1 (en) 2011-01-19
AU2006236097A1 (en) 2006-12-07
US6340672B1 (en) 2002-01-22
ES2357697T3 (es) 2011-04-28
EP1299108A1 (en) 2003-04-09

Similar Documents

Publication Publication Date Title
AU3694901A (en) A parasiticidal formulation and a method of making this formulation
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
BR0007147A (pt) Composição de tensìdio contendo tensìdio gemini e co-anfifila, sua preparação e aplicação
ATE314092T1 (de) Biologische kleber und verfahren zur topischen verabreichung von wirkstoffen
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
BR9913154A (pt) Composição de musse
BR9912975A (pt) Composto e composições para liberação de agentes ativos, método para sua obtenção e seu uso
ATE373422T1 (de) Mikroemulsionbildende herbizidkonzentrate, mikroemulsionen und verfahren
DK1158959T3 (da) Sammensætninger og fremgangsmåder til forbedret indgift af hydrofobe terapeutiske midler
DE69919863D1 (de) Stabilgelmischung in form einer mischung eines öligen gels und eines wässrigen gels
ATE324907T1 (de) Verbindung und arzneizusammensetzung zur verabreichung von wirkstoffen
SG156624A1 (en) Organo-gel formulations for therapeutic applications
BR0015567A (pt) Compostos de ácido fenoxicarboxìlico e composições para liberar agentes ativos
BR0114799A (pt) Compostos de ácido cianofenoxi carboxìlico e composições para liberar agentes ativos
ATE382057T1 (de) Stabile formulierung von modifiziertem glp-1
ES2161085T3 (es) Formulaciones que contienen oxaliplatino.
WO2001058474A3 (en) Microencapsulation and sustained release of biologically active agent
CA2567575A1 (en) Organo-gel formulations for therapeutic applications
ES2174517T3 (es) Composiciones cosmeticas con dibenciliden sorbitol y siliconas funcionalizadas.
DK0974350T3 (da) Tranilast-holdigt præparat til ydre påføring og fremgangsmåde til fremstilling af dette
WO2002019969A3 (en) (5-(2-hydroxy-4-chlorobenzoyl) aminovaleric acid and salts thereof and compositions containing the same for delivering active agents
DE60130135D1 (de) Pharmazeutische zubereitungen, die chelatbildner/sequestriermittel enthalten und deren dermatologische verwendung
ATE279910T1 (de) Tensid für äusserlich anzuwendende hautpräparate und diese beinhaltende äusserlich anzuwendende hautpräparate
BRPI0408655A (pt) formulações compreendendo um agente ativo e cacau em pó e a sua utilização
DK1280558T3 (da) Halvfast indgivelsesvehikel og farmaceutiske sammensætninger